ZOMDF — what changed in the latest 10-Q
A section-by-section comparison of ZOMDF's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-06 vs the prior 10-Q · 2025-11-04
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +14 | −16 | ~21 | 38 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3), Legal proceedings, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-06
The increase in revenue for the three months ended March 31, 2026, was primarily due to contract manufacturing and engineering revenue recognized during the current period; growth in TRUFORMA® products, including the impact of launching new assays since the end of the comparative period; growth in c…
The increase in cost of revenue for the three months ended March 31, 2026, was primarily driven by increased manufacturing expense resulting from higher unit sales as well as increased salaries and wages associated with our manufacturing and engineering operations. We anticipate that costs of revenu…
Gross profit margin for the three months ended March 31, 2026 was 62%, compared to 68% for the three months ended March 31, 2025.
The decrease in gross profit margin percentage for the three months ended March 31, 2026, was primarily due to the impact of the change in product mix associated with our unit sales.
General and administrative expense for the three months ended March 31, 2026 was $5,413, compared to $6,262 for the three months ended March 31, 2025, a decrease of $849, or 14%.
Text removed vs the prior filing · source: 10-Q · 2025-11-04
The increase in revenue for the three months ended September 30, 2025, was primarily due to contract manufacturing and engineering revenue recognized during the current period; growth in TRUFORMA® products, including the impact of launching new assays since the end of the comparative period; growth …
The increase in cost of revenue for the three months ended September 30, 2025, was primarily driven by increased manufacturing expense resulting from higher unit sales as well as higher depreciation expense associated with capital projects completed in the second half of 2024. The increase in cost o…
Gross profit margin for the three months ended September 30, 2025 was 67%, compared to 72% for the three months ended September 30, 2024. Gross profit margin for the nine months ended September 30, 2025 was 67%, compared to 70% for the nine months ended September 30, 2024.
The decrease in gross profit margin percentage for the three months ended September 30, 2025, was primarily due to higher depreciation expense associated with capital projects completed in the second half of 2024 and the impact of the change in product mix associated with our unit sales. The decreas…
General and administrative expense for the three months ended September 30, 2025 was $5,900, compared to $6,765 for the three months ended September 30, 2024, a decrease of $865, or 13%. General and administrative expense for the nine months ended September 30, 2025 was $18,324, compared to $23,366 …
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice